Table 3. Characteristics of the SU-Dependent Subjects (n=19).

Variable	Value
Age, yr	67±11
Male sex, %	57.9
Weight, kg	65.3±10.6
Body mass index, kg/m2	25.1±3.1
Duration of diabetes, yr	18±10
DM in 1st degree family, %	73.7
Systolic blood pressure, mm Hg	134.9±14.6
Diastolic blood pressure, mm Hg	76.2±12.1
Glycated hemoglobin, %	6.7±0.4
Fasting serum glucose, mg/dL	129.2±20.2
C-peptide (n=10), ng/mL	3.9±2.6
Total cholesterol, mg/dL	150.8±35.3
Triglyceride, mg/dL	113.5±51.8
Urine albumin/creatinine ratio, mg/g	21.2±16.6
eGFR, mL/min/1.73 m2	75.8±18.0
SU duration, yr	12±9
SU, number (%)/mean dose, mg/day
Glimepiride	8 (42.1)/1.1±0.8
Gliclazide	4 (21.1)/70.0±20.0
Gliclazide modified release	2 (10.5)/30±0
Glibenclamide	5 (26.3)/2.5±1.5

Values are expressed as mean±SD.

SU, sulfonylurea; eGFR, estimated glomerular filtration rate.